科学・政策と社会ニュースクリップ

科学政策や科学コミュニケーション等の情報をクリップしていきます。

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
●Follow the leader
http://www.nature.com/nature/journal/v453/n7197/full/453851a.html

▼If Japan is to become a front-runner in pharmaceutical development, it must not only speed up its approval of new drugs, but also enhance its own research capabilities, argue Kaori Tsuji and Kiichiro Tsutani.

▼辻 香織氏、津谷 喜一郎氏
http://www.f.u-tokyo.ac.jp/~utdpm/

●欧米新薬の審査緩和、後発薬促進で…規制改革会議の報告案
http://www.yomiuri.co.jp/politics/news/20080610-OYT1T00417.htm

原爆症集団訴訟、仙台・大阪高裁判決確定へ…原告も上告せず
http://www.yomiuri.co.jp/national/news/20080611-OYT1T00390.htm

ハンセン病基本法成立 全国の療養所を一般市民に開放
http://mainichi.jp/select/science/archive/news/2008/06/11/20080611dde007040069000c.html

●医療死亡事故:24時間内、届け出義務 命令違反に懲役刑も−−安全調査委設置大綱案
http://mainichi.jp/select/science/archive/news/2008/06/13/20080613dde007040042000c.html

●「薬剤師余り」への対応策を議論
http://www.cabrain.net/news/article/newsId/16585.html

●「薬剤師に採血や聴診器を」
http://www.cabrain.net/news/article/newsId/16589.html

●To thwart disease, apply now
http://www.nature.com/nature/journal/v453/n7197/full/453823a.html

▼Translational medicine is a key addition to the biomedical research enterprise. Policy-makers and research leaders now must build the infrastructure to take discoveries from the bench to application.

●Translational research: Getting the message across
http://www.nature.com/news/2008/080611/full/453839a.html

●Translational research: Crossing the valley of death
http://www.nature.com/news/2008/080611/full/453840a.html

●Translational research: The full cycle
http://www.nature.com/news/2008/080611/full/453843a.html

●Translational research: A case history
http://www.nature.com/news/2008/080611/full/453846a.html

●35疾患患者集団の一塩基多型情報公開
http://scienceportal.jp/news/daily/0806/0806111.html

▼がんや心臓疾患、脳障害など35疾患のSNP頻度情報を公開
−病気や薬の副作用と関係する遺伝子の発見につながると期待−
http://www.jst.go.jp/pr/announce/20080611/

●New task force to tackle 'stem-cell tourism'
http://www.newscientist.com/channel/health/dn14137-new-task-force-to-tackle-stemcell-tourism.html

▼Worried by websites selling unproven and possibly risky stem-cell therapies, experts are drafting guidelines for patients and regulators

                                                                                                                                • -